In addition, the CCK-8 assay demonstrated that the TPM3P9-mediated proliferative phenotype of ccRCC cells was inhibited by the silencing of TCF7L2-L, SAM68, or RELB (Fig. 8p). This evidence concerns the gene RELB and nonpapillary renal cell carcinoma.